# TABRECTA

NDC: 0078-0709
Generic name: capmatinib
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20200506

FDA application: NDA213591

## Active ingredients

- CAPMATINIB HYDROCHLORIDE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0709"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0709
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=455892c3-d144-4ba8-9ab4-79cabff9876d